The development and testing of a device to enhance the application of repetitive transcranial magnetic stimulation. This project aims to develop and evaluate a new device designed to substantially enhance the use of transcranial magnetic stimulation, a technology, which is increasingly being applied in the treatment of disorders such as depression, as well as in the study of normal and abnormal brain function.
Use of an animal model to understand mechanisms underlying reductions in body weight associated with use of the laparoscopic adjustable gastric band. At least one in ten Australians is classified as morbidly obese and as such are eligible for bariatric surgery. Those undergoing the surgery will achieve an average excess weight loss of up to 60 per cent, they will have reduced or eliminated diabetes and will appreciably improve their prospects of survival. These experiments aimed at understandin ....Use of an animal model to understand mechanisms underlying reductions in body weight associated with use of the laparoscopic adjustable gastric band. At least one in ten Australians is classified as morbidly obese and as such are eligible for bariatric surgery. Those undergoing the surgery will achieve an average excess weight loss of up to 60 per cent, they will have reduced or eliminated diabetes and will appreciably improve their prospects of survival. These experiments aimed at understanding the mechanisms underpinning this success have the potential to further improve surgical approaches and outcomes and provide insights that will better enable weight loss therapies for all overweight and obese Australians.Read moreRead less
Identifying genes that influence clinical course and susceptibility in multiple sclerosis. This project aims to identify the genetic basis of multiple sclerosis (MS), the most common neurologic disease in young Australian adults. MS urgently needs research to identify predisposition, aid early diagnosis and provide bona fide molecular targets for new therapies. This will benefit people with MS and those susceptible to it. Crucial new knowledge identified will benefit other major areas of MS rese ....Identifying genes that influence clinical course and susceptibility in multiple sclerosis. This project aims to identify the genetic basis of multiple sclerosis (MS), the most common neurologic disease in young Australian adults. MS urgently needs research to identify predisposition, aid early diagnosis and provide bona fide molecular targets for new therapies. This will benefit people with MS and those susceptible to it. Crucial new knowledge identified will benefit other major areas of MS research including epidemiology, immunology and neurobiology. Collaboration of 8 major Australian institutions is also important for this project and future studies. The team will have access to a new national MS GeneBank (platform) with samples from 2240 patients that should generate findings important to world-wide MS genetic knowledge.Read moreRead less
New Imaging Agents for Neuronal Nicotinic Receptors. Recent advances in medical imaging technology such as Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT) have radically improved the diagnosis and treatment of a wide range of diseases. The aim of this project is to discover novel radio-ligands that selectively bind to neuronal nicotinic acetylcholine receptors. These ligands will have great potential for the imaging, diagnosis and study of neurodegenerat ....New Imaging Agents for Neuronal Nicotinic Receptors. Recent advances in medical imaging technology such as Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT) have radically improved the diagnosis and treatment of a wide range of diseases. The aim of this project is to discover novel radio-ligands that selectively bind to neuronal nicotinic acetylcholine receptors. These ligands will have great potential for the imaging, diagnosis and study of neurodegenerative diseases such as Alzheimer's disease. Read moreRead less
Increasing the utility of tetanus toxins by protein engineering. There are a variety of common diseases that are the result of muscular defects. Some of these may be able to be treated with an agent that increases muscle tone, thereby giving benefit to the patient in the alleviation of symptoms. This project aims to use some of the most potent substances known, bacterial toxins, and engineer them to be valuable agents for treatment of certain muscular disorders.
New Conus-derived alpha-conotoxin analgesics for the treatment of chronic pain: structure, mode of action, delivery and disposition. Current product deficiencies in the area of pain management are forcing the pharmaceutical industry to develop new strategies for achieving analgesia and reduce their dependence on traditional, addictive opiate-based products. Structural modification of cone snail derived peptides will provide exciting new leads for achieving effective analgesia.
Prediction of epilepsy seizure onset using nonlinear analysis of EEG recordings. This project will develop the theory and algorithms for reliable and robust prediction of the onset of epileptic seizures and the characterisation of epileptic seizures based on EEG data. Our interdisciplinary team consists of neuroscientists and systems engineers supported with clinicians and software developers. The team will develop the theory and design, implement and evaluate decision support software that is a ....Prediction of epilepsy seizure onset using nonlinear analysis of EEG recordings. This project will develop the theory and algorithms for reliable and robust prediction of the onset of epileptic seizures and the characterisation of epileptic seizures based on EEG data. Our interdisciplinary team consists of neuroscientists and systems engineers supported with clinicians and software developers. The team will develop the theory and design, implement and evaluate decision support software that is able to interpret eeg data and present epilepsy relevant information to clinicians and patients. Our methods are based on statistical signal processing, nonlinear dynamics (bifurcation and time-series methods) and systems engineering (system identification, adaptive methods).Read moreRead less
Development of the PD GeneChip: a research and diagnostic tool for Parkinson's disease. The PD GeneChip will provide both social and economic benefits to Australia. It will be a key research platform for Australian scientists, and will facilitate collaboration both within Australia and overseas. It will assist with health care management of PD (Parkinson's disease) patients by providing a cost-effective diagnostic tool and the possibility of predicting the clinical course of disease. This inform ....Development of the PD GeneChip: a research and diagnostic tool for Parkinson's disease. The PD GeneChip will provide both social and economic benefits to Australia. It will be a key research platform for Australian scientists, and will facilitate collaboration both within Australia and overseas. It will assist with health care management of PD (Parkinson's disease) patients by providing a cost-effective diagnostic tool and the possibility of predicting the clinical course of disease. This information will provide the basis for tailoring treatment to a patients needs. It is anticipated that marketing of the PD GeneChip within Australia and overseas may produce revenue of at least $40 million annually.Read moreRead less
Optimisation of signal processing and electrical stimulation algorithms for the abatement of epileptic seizures. Epilepsy is the second-most common neurological disorder behind stroke and ischemic attacks, affecting 1-2 per cent of the nation's population. Pharmaceutical therapies are ineffective in approximately one third of cases, the result being a large unmet need for novel treatments. The devices to be produced through this project will improve the quality of life of many patients in the fu ....Optimisation of signal processing and electrical stimulation algorithms for the abatement of epileptic seizures. Epilepsy is the second-most common neurological disorder behind stroke and ischemic attacks, affecting 1-2 per cent of the nation's population. Pharmaceutical therapies are ineffective in approximately one third of cases, the result being a large unmet need for novel treatments. The devices to be produced through this project will improve the quality of life of many patients in the future and alleviate their dependence on traditional medications. The devices will also reduce the patients' requirements for medical practitioners, hospital and ambulance services, and will therefore also reduce the financial burden that neurological and epilepsy patients place on the community.Read moreRead less
Quantitative measurement of Schizophrenia using Electrovestibulography. Schizophrenia was estimated to cost approximately $1.85billion in 2001 (0.3% of GDP and nearly $50k for each of the 37,000 Australians with the illness). Over one third of the cost is borne by sufferers and their carers. Misdiagnosis and incorrect therapy are common. To date quantitative assessment of Schizophrenics has been impossible making this tool potentially invaluable. An accurate diagnostic test could facilitate earl ....Quantitative measurement of Schizophrenia using Electrovestibulography. Schizophrenia was estimated to cost approximately $1.85billion in 2001 (0.3% of GDP and nearly $50k for each of the 37,000 Australians with the illness). Over one third of the cost is borne by sufferers and their carers. Misdiagnosis and incorrect therapy are common. To date quantitative assessment of Schizophrenics has been impossible making this tool potentially invaluable. An accurate diagnostic test could facilitate earlier diagnosis, more accurate treatment plans, and prevention of debilitating psychotic episodes for the sufferer. By being able to monitor drug efficacy the community can benefit by reduced drug costs, confinement times and hastened new drug development. Read moreRead less